Calendar of Events
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Featured Speaker: Serena H. Chan, MD, FACOG – “Gynecologic Surgery in Pediatric/Adolescent Patients: Special Considerations & Management of Mullerian Anomalies”
About Dr. Chan
Serena H. Chan, MD, FACOG, is Chief of the Pediatric & Adolescent Gynecology division at UPMC Children’s Hospital of Pittsburgh. She is also an Assistant Professor of Obstetrics, Gynecology & Reproductive Sciences at the University of Pittsburgh School of Medicine. She is board-certified in obstetrics and gynecology by the American Board of Obstetrics and Gynecology.
Dr. Chan earned her Medical Degree from Oregon Health and Science University before completing her Residency in Obstetrics and Gynecology at UPMC Magee-Womens Hospital. She also completed a Fellowship in Pediatric and Adolescent Gynecology Fellowship at Cincinnati Children’s Hospital.
Dr. Chan’s clinical specialties include medical and surgical management of pediatric and adolescent gynecologic concerns, congenital abnormalities of the female reproductive tract, and fertility preservation and reproductive endocrine issues in girls undergoing gonadotoxic therapy. Her research interests include gynecological concerns in females with anorectal malformations, trainee education in provision of adolescent reproduction health services. She has published and presented on the topics of surgical management of reproductive tract anomalies, fertility preservation, and gynecologic concerns in adolescent/young adult cancer survivors. She is a member of the North American Society for Pediatric/Adolescent Gynecology (NASPAG), the American Society for Reproductive Medicine (ASRM), the American Association of Gynecologic Laparoscopists (AAGL), and the American College of Obstetricians and Gynecologists (ACOG).
Register via Zoom for those not able to attend in person
Learn more about the E. James Aiman, MD, Endowed Lectureship[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]Resident and Fellow Research and Alumni Day is an annual event where our residents and graduating fellow present their clinical, translational science, and educational research results within their residency and fellowship in the Department of Obstetrics and Gynecology.[/vc_column_text][vc_separator type=”normal” thickness=”3″][vc_empty_space height=”20px”][/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column width=”1/2″][vc_column_text]You must register for this in-person event:[/vc_column_text][vc_empty_space height=”12px”][/vc_column][vc_column width=”1/2″]Register Now![/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_separator type=”normal” thickness=”3″][vc_column_text]
Schedule:
[/vc_column_text][vc_column_text]
| Time | Activity |
|---|---|
| 7:15am | BREAKFAST |
| 7:45am | WELCOME & INTRODUCTIONS |
| 8:00am | Yiwen Cui, MD, MFM Fellow O-GlcNAc transferase contributes to sex-specific placental deregulation in gestational diabetes Mentor: Stephanie Olivier-Van Stichelen, PhD |
| 8:15am | Lindsay McAlarnen, MD GYN ONC Fellow Exosomal FXR1 as a translational mediator in the ovarian cancer microenvironment Mentor:Pradeep Chaluvally-Raghavan, PhD |
| 8:30am | Rebekah Summey, MD GYN ONC Fellow Exploration and exploitation of hormonal pathways in adult granulosa cell tumors for development of targeted therapeutics Mentors: Elizabeth Hopp, MD and Janet S. Rader, MD |
| 8:45am | Alex Levy, MD, R4 Is One Superior? Comparison of Early Removal Rates of Intrauterine Device versus Nexplanon Subdermal Implant in Women Ages 16-24 in Milwaukee, Wisconsin Mentor: Jessica Francis, MD |
| 9:00am | Rana Aliani, MD R3 Impact of Race, Insurance, and Procedural Timing on Sterilization Method Mentor: Ben Beran, MD |
| 9:15am | Mary Siracusa, MD R3 Determining Patients’ Preferred Ultrasound Provider During the Preoperative Evaluation of Endometriosis Mentor: Ben Beran, MD |
| 9:30am | BREAK |
| 9:45am | Iman Khan, MD R3 Postpartum Care in a Post-COVID Era Mentors: Amy Domeyer, MD and Erika Peterson, MD |
| 10:00am | Blake Neuburg, MD R3 Inpatient Versus Outpatient Management of Gestational Hypertension or Preeclampsia Without Severe Features Mentor: Anna Palatnik, MD |
| 10:15am | Ankita Sarawagi, MD R3 Screening rates for intimate partner violence (IPV) in the OBGYN clinic from 2019 to 2022 Mentor: Kim Gecsi, MD |
| 10:30am | Margaret Bruce, MD R3 Evaluating Modern Contraceptive Methods as Risk Factors for Recurrent UTI’s Mentor: Sumana Koduri, MD |
| 10:45am | BREAK |
| 11:00am | The Roland S. Cron Lecture: Nandini Raghuraman, MD, MS Fellowship Program Director, Maternal-Fetal Medicine Assistant Professor, OB/GYN Washington University School of Medicine "Moving Evidence into Clinical Practice on Labor & Delivery" |
| 12:00pm | Questions for Dr. Raghuraman |
| 12:30pm | Lunch |
Featuring The Roland S. Cron Lectureship
Guest Speaker
Nandini Raghuraman, MD MSCI
Fellowship Program Director, Maternal-Fetal Medicine
Assistant Professor, OB/GYN
Washington University School of Medicine
About Dr. Raghuraman
Nandini Raghuraman, MD, MSCI, is an Assistant Professor in the Division of Maternal-Fetal Medicine at Washington University in St Louis and the MFM Fellowship Program Director. She is a NIH-funded physician scientist with expertise in Labor & Delivery clinical trials and implementation science in obstetrics. She has authored over 70 peer reviewed manuscripts and is currently leading a multicenter randomized trial investigating the effect of maternal oxygen supplementation in labor for fetal resuscitation.
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Presented by
Wei Xu, PhD
Professor of Oncology, Marian A. Messerschmidt
Associate Director,, McArdle Laboratory for Cancer Research
Director of MCW Tissue Bank
Co-Director, Genetic and Epigenetic Mechanism Program, Carbone Cancer Center
About
Dr. Xu’s laboratory explores the protective roles of environmental and nutritional estrogenic compounds in mammals for breast cancer prevention and treatment. Estrogen receptors (ERs) exist in two forms, ERa and ERb, which have opposing roles in cell proliferation. Estrogenic compounds can control balance between mammary cell proliferation and differentiation via stimulating the formation of different forms of ER dimers. Xu lab has developed the Bioluminescent Resonance Energy Transfer (BRET) assays for detecting in vivo homodimerization and heterodimerization of ERa and ERb induced by estrogenic compounds. Biological functions of these estrogenic compounds are currently being investigated in cell-based and breast cancer mouse models. Dr. Xu’s laboratory has also employed biochemical and functional genomic approaches, as well as mouse genetics to decipher the contribution of histone arginine methylation to the epigenetic control of cancer cells. The major focus of Xu lab is on a protein arginine (R) methyltransferase CARM1/PRMT4, a nuclear hormone receptor co-activator. Dr. Xu has identified a number of non-histone substrates for CARM1 and is in the progress of elucidating the functions of protein arginine methylation in breast cancer initiation and progression.
Learn more about the WHRP Seminars[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Featured Speaker: George B. Mychaliska, MD – “Leveraging Intrauterine Physiology – Fetal Surgery and the Artificial Placenta”
George B. Mychaliska, MD
Professor, Pediatric Surgery, Surgery
University of Michigan Health
George B. Mychaliska, M.D. is the Robert Bartlett, MD Collegiate Professor of Pediatric Surgery and a Professor of Obstetrics and Gynecology at the University of Michigan. He earned his Medical Degree and Master’s of Science from the Joint Medical Program at the University of California at San Francisco and Berkeley. He completed his General Surgery residency and Fetal Surgery fellowship at UCSF. Dr. Mychaliska completed his Pediatric Surgery fellowship at the Children’s Hospital of Michigan. He is board certified in Pediatric Surgery and General Surgery. Dr. Mychaliska’s practice encompasses all aspects of pediatric surgery. His clinical areas of interest and expertise are prenatal diagnosis and fetal surgery. Dr. Mychaliska’s research interests include prenatal diagnosis and therapy, pulmonary development, and congenital diaphragmatic hernia.[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Presented by
Bo Wang, PhD
Director – Tissue Regenerative Engineering Laboratory (TRE Lab)
Assistant Professor – Department of Biomedical Engineering, The Marquette University and Medical College of Wisconsin
About
Dr. Bo Wang, Director and Principal Investigator of the TRE Lab, received her PhD in Biomedical Engineering from Mississippi State University in 2012 and completed her Postdoctoral Fellowship at Northwestern University’s Feinberg School of Medicine, Department of Surgery, in 2016. She joined the Marquette-MCW Joint Department of Biomedical Engineering in January of 2019 with research interests that include stem cell engineering, hard-tissue engineering and 3D bioprinting, as well as vascular tissue engineering, imaging, modeling and simulation.
The Tissue Regenerative Engineering Laboratory is developing bio-functional engineered tissues that provide advanced therapeutic options for such conditions as birth defects, bone disorders, and liver and vascular diseases. To do this, the TRE Lab will first develop a greater understanding of the biological and molecular processes involved in regenerative regression.
Learn more about the WHRP Seminars[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Featured Speaker: Kelle Moley, MD – “Women’s Health from Molecule to Market”
Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation. Kelle joined BMGF in July 2020, with a 30-year history of basic and translational research on reproductive health issues in females throughout the life course– from organismal to cellular and molecular levels of metabolic, developmental biology, embryo implantation and decidualization, and infectious diseases of the female reproductive tract.
Kelle earned her BA from Wellesley College, and her MD from Yale Medical School. Thereafter, she pursued an Obstetrics & Gynecology Residency and a Fellowship in Reproductive Endocrinology & Fertility at Washington University in St. Louis School of Medicine. Kelle then spent the next 3 decades of a thriving research career at Washington University—rising to become the James P. Crane Professor of Obstetrics & Gynecology, Vice Chair of Obstetrics & Gynecology, Chief of the Division of Basic & Translational Research for the Department of Obstetrics & Gynecology, Co-Director of the Institute of Clinical & Translational Science for the School of Medicine, and Director of the Center for Reproductive Health Sciences at the School of Medicine. Her research (published in some 150 peer-reviewed primary articles) led to an international reputation along with numerous honors, including election to the National Academy of Medicine in 2014. She also earned a reputation as a superb mentor to trainees, leading the reproductive endocrinology fellowship program at Washington University until she left academia in 2018. After a 2-year stint as Chief Scientific Officer and Senior Vice President of the March of Dimes she left to pursue her new position at BMGF.
[/vc_column_text][vc_column_text]
Given the prestige of the endowed lecture as well as our guest, please plan to be in person for attendance. There will be a zoom link for hybrid participation for extenuating circumstances and to allow the largest diversity of participation from our campus guests.
[/vc_column_text][vc_empty_space height=”20px”][vc_column_text]
Learn more about the Eleanor Delfs Lectureship for Pioneers[/vc_column_text][/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][/vc_column][/vc_row]